199 related articles for article (PubMed ID: 25224230)
21. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
Tack J
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
[TBL] [Abstract][Full Text] [Related]
22. Irritable bowel syndrome. Don't forget amitriptyline.
Leeds JS; Leeds CM; Sanders DS
BMJ; 2009 Jan; 338():a3150. PubMed ID: 19126615
[No Abstract] [Full Text] [Related]
23. [Tegaserod in treatment of women with irritable bowel syndrome].
Munck LK; Ainsworth MA
Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications of probiotics in gastrointestinal disorders in children.
Chen CC; Walker WA
Natl Med J India; 2011; 24(3):153-60. PubMed ID: 21786845
[TBL] [Abstract][Full Text] [Related]
25. In search of mechanisms of change in treatment outcome research: mediators and moderators of psychological and pharmacological treatments for irritable bowel syndrome.
Labus JS
Gastroenterology; 2007 Aug; 133(2):702-5. PubMed ID: 17681186
[No Abstract] [Full Text] [Related]
26. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872
[No Abstract] [Full Text] [Related]
27. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
[TBL] [Abstract][Full Text] [Related]
28. [Causes of functional digestive disorders and therapeutic approach in primary care medicine].
Coman AE; Popa E; Grigore C; Maidaniuc M; Petrovanu R
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):75-9. PubMed ID: 20509279
[TBL] [Abstract][Full Text] [Related]
29. [What to do the the patient with irritable bowel refractory to conventional treatment].
Schmulson MJ; Ortiz O
Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():85-8. PubMed ID: 16881204
[No Abstract] [Full Text] [Related]
30. [Pharmacologic treatments of transit disorders].
Manz M; Meier R
Ther Umsch; 2007 Apr; 64(4):227-32. PubMed ID: 17663210
[TBL] [Abstract][Full Text] [Related]
31. Complementary therapies for pediatric functional gastrointestinal disorders.
Vlieger AM; Benninga MA
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):707-9. PubMed ID: 18955886
[No Abstract] [Full Text] [Related]
32. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M
Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
[No Abstract] [Full Text] [Related]
33. [Functional gastrointestinal disorders].
Halama M
Praxis (Bern 1994); 2015 Aug; 104(16):853-7. PubMed ID: 26242420
[TBL] [Abstract][Full Text] [Related]
34. [Functional gastrointestinal disorders].
Vogt W
Praxis (Bern 1994); 2007 Nov; 96(47):1849-55. PubMed ID: 18062157
[TBL] [Abstract][Full Text] [Related]
35. Probiotics and functional gastrointestinal disorders in children.
Vandenplas Y; Benninga M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
[TBL] [Abstract][Full Text] [Related]
36. Management of irritable bowel syndrome with constipation: a flexible approach to treating a complex condition with multiple symptoms.
Layer P
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):9-14. PubMed ID: 23859755
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis: The treatment of irritable bowel syndrome.
Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
[TBL] [Abstract][Full Text] [Related]
38. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
Vahedi H; Merat S; Momtahen S; Kazzazi AS; Ghaffari N; Olfati G; Malekzadeh R
Aliment Pharmacol Ther; 2008 Apr; 27(8):678-84. PubMed ID: 18248658
[TBL] [Abstract][Full Text] [Related]
39. [Irritable bowel disease: recent developments].
Böhm SK; Kruis W
Dtsch Med Wochenschr; 2012 Oct; 137(40):2034-7. PubMed ID: 23023617
[No Abstract] [Full Text] [Related]
40. A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome.
Awad RA; Camacho S
Colorectal Dis; 2010 Nov; 12(11):1131-8. PubMed ID: 19575740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
